Pre-clinical research could generate proof of principle for future cell therapies to treat other neurodegenerative diseases, including spinal cord injury CARLSBAD, Calif. –The University of California, San Diego, The Salk Institute for Biological Studies and LifeTechnologies Corporation (NASDAQ: LIFE) today announced the initiation of studies which may lead to the future development of cell transplant […]
SANTA CLARA, Calif. and CORALVILLE, Iowa — Agilent Technologies Inc. (NYSE: A) and Integrated DNA Technologies (IDT) have partnered to provide a complete solution for qPCR studies. The combination of the Mx3005P qPCR system and Brilliant qPCR reagents from Agilent with PrimeTime qPCR Assays from IDT provides customers a fully supported solution that is ideal […]
Jena — Analytik Jena AG and SIRS-Lab GmbH, also based in Jena, will be strengthened by working together in the field of molecular sepsis diagnostics. As part of this cooperation, Analytik Jena subsidiary AJ Innuscreen GmbH will provide the partner with a platform for automated isolation of nucleic acids with the associated reagent system worth […]
Fully-validated SIRT1 Enhances Drug Discovery Investigation Wakefield, MA, and Worcester, MA — BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry’s only Sirtuin (SIRT, silent mating type information regulation homolog) enzyme preparations fully-validated in a label-free […]
Liège, Belgium — Eurogentec is pleased to announce today that its majority shareholders have entered into an agreement with Kaneka by which the latter will acquire a majority stake in Eurogentec S.A. The Delwart Family remains on the Board of Directors as an important minority shareholder. Through this agreement, Eurogentec becomes the spearhead of Kaneka […]
Madison, WI USA — Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that […]
NEW YORK — — Amalgamated Capital (AmalCap), a recently formed division of Amalgamated Bank, announced today it served as Co-Lead Arranger for a $25 million senior secured credit facility in support of the acquisition of Wheaton Industries Inc. (Wheaton) by PNC Equity Partners II, L.P. AmalCap provides cash flow-based senior debt financing to support investments […]
PORT WASHINGTON, N.Y.–New Brunswick Scientific, an Eppendorf Company (Edison, NJ, www.nbsc.com), and Pall Corporation (Port Washington, NY, www.pall.com) today announced a joint product development and marketing agreement to create and supply new disposable bioreactor systems. “This is an exciting step forward, as the new system will enable us to offer an even broader range of […]
COSTA MESA, Calif. — — DV Biologics LLC announced today that it has executed an agreement with System Biosciences LLC for the development of human-derived disease-specific induced pluripotent stem cell (iPSC) lines. iPSCs are pluripotent cells which are developed from non-pluripotent cells that have undergone gene expression changes to render them pluripotent giving them the […]
SANTA ANA, Calif.–MP Biomedicals LLC announced today that it has signed a definitive agreement to acquire the assets of ICPbio International LTD., an Auckland, New Zealand based protein biologics manufacturing company, subject to normal closing adjustments. This acquisition places MP Biomedicals in a strong position to pursue sales and distribution of serum protein products used […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
